Mannose-binding lectin and its genetic variants

Genes and Immunity

Volumn 7, Issue 2, 2006, Pages 85-94

  Garred, P ^a   Larsen, F ^a   Seyfarth, J ^a   Fujita, R ^b   Madsen, H O ^a  

^a University of Copenhagen   (Denmark)

^b UNIVERSIDAD DE SAN MARTÍN DE PORRES   (Peru)

Author keywords

Complement; Innate immunity; Mannan binding lectin; Mannose binding lectin; MBL1P1; MBL2

Indexed keywords

MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN 1; MANNOSE BINDING LECTIN 2; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ALLELE; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; COMPLEMENT ACTIVATION; DISEASE COURSE; GENE FREQUENCY; GENE SILENCING; GENETIC ORGANIZATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOST RESISTANCE; HUMAN; INFECTION; METABOLIC DISORDER; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; NONHUMAN; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW;

ALLELES; HUMANS; MANNOSE-BINDING LECTIN; MODELS, GENETIC; VARIATION (GENETICS);

EID: 33644772194     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364283     Document Type: Review

References (64)

1. Lu J, Teh C, Kishore U, Reid KB. Collectins and ficolins: Sugar pattern recognition molecules of the mammalian innate immune system. Biochim Biophys Acta 2002; 1572: 387-400.
2. Turner MW, Hamvas RMJ. Mannose-binding lectin: Structure, function, genetics and disease associations. Rev Immunogenetics 2000; 2: 305-322.
3. Kilpatrick DC. Mannan-binding lectin: Clinical significance and applications. Biochim Biophys Acta 2002; 1572: 401-413.
4. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003; 37: 1496-1505.
5. Nuytinck L, Shapiro F. Mannose-binding lectin: The stepping stones from clinical research to personalized medicine. Personalized Med 2004; 1: 35-52.
6. Casanova JL, Abel L. Human mannose-binding lectin in immunity: Friend, foe, or both? J Exp Med 2004; 199: 1295-1299.
7. Miller ME, Seals J, Kaye R, Levitsky LC. A familial, plasma associated defect of phagocytosis: New cause of recurrent bacterial infection. Lancet 1968; 2: 60-63.
8. Turner MW, Mowbray JF, Roberton DR. A study of C3b deposition on yeast surfaces by sera of known opsonic potential. Clin Exp Immunol 1981; 46: 412-419.
9. Kawasaki T, Etoh R, Yamashina I. Isolation and characterization of mannan-binding protein from rabbit liver. Biochem Biophys Res Commun 1978; 81: 1018-1024.
10. Kawasaki N, Kawasaki T, Yamashina I. Isolation and characterization of mannan-binding protein from human serum. J Biochem (Tokyo) 1983; 94: 937-947.
11. Ikeda K, Sannoh H, Kawasaki N, Kawasaki T, Yamashina I. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem 1987; 262: 7451-7454.
12. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan-binding protein with a common defect in opsonisation. Lancet 1989; 2: 1236-1239.
13. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose- binding protein in association with a novel C1s-like serine protease. J Exp Med 1992; 176: 1497-1503.
14. Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, Poulsen K et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997; 386: 506-510.
15. Dahl MR, Thiel S, Matsushita M, Fujita T, Willis AC, Christensen T et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 2001; 15: 127-135.
16. Takahashi M, Endo Y, Fujita T, Matsushita M. A truncated form of mannose-binding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway. Int Immunol 1999; 11: 859-863.
17. Stover CM, Thiel S, Thelen M, Lynch NJ, Vorup-Jensen T, Jensenius JC et al. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J Immunol 1999; 162: 3481-3490.
18. Liu Y, Endo Y, Iwaki D, Nakata M, Matsushita M, Wada I et al. Human m-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol 2005; 175: 3150-3156.
19. Matsushita M, Endo Y, Fujita T. Cutting edge: Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J Immunol 2000; 164: 2281-2284.
20. Matsushita M, Kuraya M, Hamasaki N, Tsujimura M, Shiraki H, Fujita T. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J Immunol 2002; 168: 3502-3506.
21. Taylor ME, Brickell PM, Craig RK, Summerfield JA. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J 1989; 262: 763-771.
22. Sastry K, Herman GA, Day L, Deignan E, Bruns G, Morton CC et al. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med 1989; 170: 1175-1189.
23. Guo N, Mogues T,Weremowicz S, Morton CC, Sastry KN. The human ortholog of rhesus mannose-binding protein-A gene is an expressed pseudogene that localizes to chromosome 10. Mamm Genome 1998; 9: 246-249.
24. Sastry R, Wang JS, Brown DC, Ezekowitz RA, Tauber AI, Sastry KN. Characterization of murine mannose-binding protein genes Mbl1 and Mbl2 reveals features common to other collectin genes. Mamm Genome 1995; 6: 103-110.
25. White RA, Dowler LL, Adkinson LR, Ezekowitz RAB, Sastry KN. The murine mannose-binding protein genes (MBL1 and MBL2) localize to chromosomes 14 and 19. Mamm Genome 1994; 5: 807-809.
26. Mogues T, Ota T, Tauber AI, Sastry KN. Characterization of two mannose-binding protein cDNAs from rhesus monkey (Macaca mulatta): structure and evolutionary implications. Glycobiology 1996; 6: 543-550.
27. Palaniyar N, Nadesalingam J, Clark H, Shih MJ, Dodds AW, Reid KB. Nucleic acid is a novel ligand for innate immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin. J Biol Chem 2004; 279: 32728-32736.
28. Naito H, Ikeda A, Hasegawa K, Oka S, Uemura K, Kawasaki N et al. Characterization of human serum mannan-binding protein promoter. J Biochem (Tokyo) 1999; 126: 1004-1012.
29. Seyfarth J, Garred P, Madsen HO. Extra-hepatic transcription of the human mannose-binding lectin (mbl2) and the MBL-associated serine protease1-3 genes. Mol Immunol 2005; doi: 10.1016/j.molimm.2005.06.033.
30. Ezekowitz RAB, Day LE, Herman GA. A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J Exp Med 1988; 167: 1034-1046.
31. Lu J, Thiel S, Wiedemann H, Timpl R, Reid KBM. Binding of the pentamer/ hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. J Immunol 1990; 144: 2287-2294.
32. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol Immunol 2003; 40: 73-84.
33. Larsen F, Madsen HO, Sim RB, Koch C, Garred P. Disease-associated mutations in human mannose-binding lectin compromise oligomerisation and activity of the final protein. J Biol Chem 2004; 279: 21302-21311.
34. Teillet F, Dublet B, Andrieu JP, Gaboriaud C, Arlaud GJ, Thielens NM. The two major oligomeric forms of human mannan-binding lectin: Chemical characterization, carbohydrate-binding properties, and interaction with MBL-associated serine proteases. J Immunol 2005; 174: 2870-2877.
35. Jensen PH, Weilguny D, Matthiesen F, McGuire KA, Shi L, Hojrup P. Characterization of the oligomer structure of recombinant human mannan-binding lectin. J Biol Chem 2005; 280: 11043-11051.
36. Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW. Distinct physicochemical characteristics of human mannose binding protein (MBP) expressed by individuals of differing genotype. Immunology 1995; 85: 660-667.
37. Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, Turner MW et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991; 337: 1569-1570.
38. Garred P, Thiel S, Madsen HO, Ryder LP, Jensenius JC, Svejgaard A. Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol 1992; 90: 517-521.
39. Garred P, Madsen HO, Kurtzhals JAL, Lamm LU, Thiel S, Hey AS et al. Diallelic polymorphism may explain variations of blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur J Immunogenetics 1992; 19: 403-412.
40. Lipscombe RJ, Sumiya M, Hill AV, Lau YL, Levinsky RJ, Summerfield JA et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Gen 1992; 1: 709-715.
41. Madsen HO, Garred P, Kurtzhals JAL, Lamm LU, Ryder LP, Thiel S et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994; 40: 37-44.
42. Madsen HO, Garred P, Thiel S, Kurtzhals JAL, Lamm LU, Ryder LP et al. Interplay between promoter-and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155: 3013-3020.
43. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from Southeast Africa and South America. J Immunol 1998; 161: 3169-3175.
44. Skalnikova H, Freiberger T, Chumchalova J, Grombirikova H, Sediva A. Cost-effective genotyping of human MBL2 gene mutations using multiplex PCR. J Immunol Methods 2004; 295: 139-147.
45. Sullivan KE, Wooten C, Goldman D, Petri M. Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39: 2046-2051.
46. Bernig T, Taylor JG, Foster CB, Staats B, Yeager M, Chanock SJ. Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection. Genes Immun 2004; 5: 461-476.
47. Bernig T, Breunis W, Brouwer N, Hutchinson A, Welch R, Roos D et al. An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 3′ haplotypes could modify circulating levels of mannose-binding lectin. Hum Genet 2005; doi: 10.1007/s00439-005-0053-5.
48. Seyfarth J, Garred P, Madsen HO. The 'involution' of mannose-binding lectin. Hum Mol Gen 2005; 19: 2859-2869.
49. Verga Falzacappa MV, Segat L, Puppini B, Amoroso A, Crovella S. Evolution of the mannose-binding lectin gene in primates. Genes Immun 2004; 5: 653-661.
50. Terai I, Kobayashi K, Matsushita M, Miyakawa H, Mafune N, Kikuta H. Relationship between gene polymorphisms of mannose-binding lectin (MBL) and two molecular forms of MBL. Eur J Immunol 2003; 33: 2755-2763.
51. Roos A, Garred P, Wildenberg ME, Lynch NJ, Munoz JR, Zuiverloon TC et al. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol 2004; 34: 2589-2598.
52. Lee SG, Yum JS, Moon HM, Kim HJ, Yang YJ, Kim HL et al. Analysis of mannose-binding lectin 2 (MBL2) genotype and the serum protein levels in the Korean population. Mol Immunol 2005; 42: 969-977.
53. Dean MM, Heatley S, Minchinton RM. Heteroligomeric forms of codon 54 mannose binding lectin (MBL) in circulation demonstrate reduced in vitro function. Mol Immunol 2005, doi:10.1016/j.molimm.2005.06.023.
54. Matsushita M, Ezekowitz RA, Fujita T. The Gly-54→Asp allelic form of human mannose-binding protein (MBP) fails to bind MBP-associated serine protease. Biochem J 1995; 311: 1021-1023.
55. Wallis R, Lynch NJ, Roscher S, Reid KB, Schwaeble WJ. Decoupling of carbohydrate binding and MASP-2 autoactivation in variant mannose-binding lectins associated with immunodeficiency. J Immunol 2005; 175: 6846-6851.
56. Ma Y, Uemara K, Oka S, Kozutsumi Y, Kawasaki N, Kawasaki T. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: Mannan binding protein dependent cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1999; 1999: 371-375.
57. Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A. Dual role of mannan-binding protein in infections: Another case of heterosis? Eur J Immunogenetics 1994; 21: 125-131.
58. Takahashi K, Gordon J, Liu H, Sastry KN, Epstein JE, Motwani M et al. Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis. Microbes Infect 2002; 4: 773-784.
59. Shi L, Takahashi K, Dundee J, Shahroor-Karni S, Thiel S, Jensenius JC et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 2004; 199: 1379-1390.
60. Mead R, Jack D, Pembrey M, Tyfield L, Turner M. Mannose-binding lectin alleles in a prospectively recruited UK population. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Lancet 1997; 349: 1669-1670.
61. Garred P, Nielsen MA, Kurtzhals JA, Malhotra R, Madsen HO, Goka BQ et al. Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes. Infect Immun 2003; 71: 5245-5253.
62. Lipscombe RJ, Beatty DW, Ganczakowski M, Goddard EA, Jenkins T, Lau YL et al. Mutations in the human mannose-binding protein gene: Frequencies in several population groups. Eur J Hum Genet 1996; 4: 13-19.
63. Juliger S, Kremsner PG, Alpers MP, Reeder JC, Kun JF. Restricted polymorphisms of the mannose-binding lectin gene in a population of Papua New Guinea. Mutat Res 2002; 505: 87-91.
64. Turner MW, Dinan L, Heatley S, Jack DL, Boettcher B, Lester S et al. Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians. Hum Mol Gen 2000; 9: 1481-1486.